Valproic Acid Syndrome: A Mini Review
Anna Cláudia Ferreira Nunes, Anna Luiza de Araújo Ribeiro, Maria Tereza Gonçalves-Mendes, Tales Alexandre Aversi-Ferreira
International Neuropsychiatric Disease Journal · pp. 35–46 · Published 2 Sep 2023
10.9734/indj/2023/v20i3398Abstract
Aims: To provide a systematic review on the occurrence of valproic acid syndrome, to, among others, elucidate the characteristics of this syndrome. Study Design: A systematic review was performed. Place and Duration of Study: Laboratory of Biomathematics of the Federal UINiversity of Alfenas, Minas Gerais State, Brazil, between June 2022 and July 2023. Methodology: A systematic search of articles was performed using the CAPES Periodic plataform a searcher from the Education Ministry of Brazil that contains Web of Science, Scopus, MedLine and other bases, from 1984 to 2023. For this review, the subject’s “syndrome of valproic acid”, “valproic acid syndrome and toxicity”, “valproic acid syndrome and malformations” were searched together using the type of material “articles” in English language. Some articles about “pregnancy’s cares” were used for epistemological composition of this work content subjects as, for instance, “general toxicity” and “others (development; health care; …)”. Results: From the 1061 articles after the exclusion and the inclusion criteria made with the subjects most pertinent to the objectives of this work, added with the subjects “pregnancy cares” and “others”; 1005 articles were excluded, remaining 56 ones. Four of total from 56 texts were 4 about “general toxicity”; 19 about “others”; 4 about “Pregnancy cares” and 29 about “valproic acid”. Conclusion: The analysis of the articles studied in this work indicates that valproic acid is a teratogen that leads to a syndrome that receives its name in fetuses whose mothers use it as an anticonvulsant and mood stabilizer primarily used for treating conditions like epilepsy and bipolar disorder, causing several physical defects in general and behavioral defects due to the impairment of the neural system. In this sense, it is essential that the team caring for pregnant women know the history of the pregnant woman and check all the medications she is using and replace those with a teratogenic potential, especially if the patient has a diagnosis of mental illness such as depression.
Cited by 1
J. Reid Black, Elizabeth Hovis, Meredith L. Spada · Journal of the Academy of Consultation-Liaison Psychiatry · 2025
Related research
- Liver Profile of Artemether-lumefantrine-tinidazole in Healthy and Parasitized Mice — shares topic coverage
- Detection of Multiple Cry Genes in Bacillus thuringiensis Isolated from Different Soil Types in Zaria — shares topic coverage
- Bioavailability and Toxicity of Plastic Contaminants to Soil and Soil Bacteria — shares topic coverage
- Botulinum Toxin: A Friend or an Enemy? — shares topic coverage
- Inhibitory Effects of Phenolic Monomers on Methanogenesis in Anaerobic Digestion — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.